Longduoduo Co

Longduoduo Co ROE

The Return on Equity (ROE) of Longduoduo Co (LDDD) as of Nov 7, 2026 is -82.23 %. In the previous year, Return on Equity (ROE) was 38.87 % — a change of -311.55% (lower).

ROE

-82.23 %

YoY

-311.55%

Last updated:

In 2026, Longduoduo Co's return on equity (ROE) was -82.23 %, a -311.55% increase from the 38.87 % ROE in the previous year.

The Longduoduo Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2020
0.00 USD
Jan 1, 2021
98.33 USD
Jan 1, 2022
809.38 USD
Jan 1, 2023
7.21 USD
Jan 1, 2024
178.71 USD
Jan 1, 2025
38.87 USD
Jan 1, 2026
-82.23 USD
The Longduoduo Co ROE history
YEARROEYoY
-82.23 %-311.55%
38.87 %-78.25%
178.71 %+2,377.73%
7.21 %-99.11%
809.38 %+723.11%
98.33 %—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Longduoduo Co Stock analysis

What does Longduoduo Co do? Longduoduo Co Ltd operates in the Health Care Providers & Services industry, focusing on preventive care for cardiovascular and cerebrovascular diseases such as myocardial infarction and cerebral infarction. The company collaborates with third-party healthcare service providers to offer preventive healthcare solutions, including health products and medical examinations. Its primary market is domestic, serving customers seeking preventive services for conditions like hemiplegia and cardiovascular diseases. The firm's revenue comes from providing these integrated preventive care services through its partnerships and domestic operations. Longduoduo Co Ltd generates income by delivering preventive healthcare solutions that combine health products with medical examinations and services. The company partners with third-party healthcare service providers to expand its service offerings, targeting individuals concerned about cardiovascular and cerebrovascular health risks. Domestic customers purchase these preventive care packages, which address specific health issues including myocardial infarction prevention and hemiplegia management. The business model relies on domestic market sales of these integrated health solutions. The company's revenue streams are derived from domestic sales of preventive healthcare services, including health products and medical examinations provided through third-party partnerships. Longduoduo focuses on cardiovascular and cerebrovascular disease prevention, targeting customers interested in avoiding conditions like myocardial infarction and cerebral infarction. Its services are designed to address specific health concerns such as hemiplegia, with the firm operating exclusively within the domestic market to deliver these preventive care solutions. Longduoduo Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Longduoduo Co's Return on Equity (ROE)

Longduoduo Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Longduoduo Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Longduoduo Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Longduoduo Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Longduoduo Co stock

Return on Equity (ROE) of Longduoduo Co is -82.23 % in 2026.

Return on Equity (ROE) of Longduoduo Co changed from 38.87 % to -82.23 %, representing a -311.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Longduoduo Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Longduoduo Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Longduoduo Co

All Key Metrics — Longduoduo Co